19-55166417-C-T
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 2P and 14B. PM2BP4_ModerateBP6_Very_StrongBS1
The NM_001256715.2(DNAAF3):c.-4G>A variant causes a splice region, 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,613,936 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001256715.2 splice_region, 5_prime_UTR
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAAF3 | NM_001256715.2 | c.-4G>A | splice_region_variant, 5_prime_UTR_variant | 2/12 | ENST00000524407.7 | ||
DNAAF3-AS1 | XR_007067344.1 | n.955C>T | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAAF3 | ENST00000524407.7 | c.-4G>A | splice_region_variant, 5_prime_UTR_variant | 2/12 | 1 | NM_001256715.2 | A2 | ||
DNAAF3-AS1 | ENST00000591665.1 | n.1186+3616C>T | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.00137 AC: 209AN: 152218Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000431 AC: 107AN: 248092Hom.: 0 AF XY: 0.000312 AC XY: 42AN XY: 134708
GnomAD4 exome AF: 0.000172 AC: 252AN: 1461602Hom.: 0 Cov.: 32 AF XY: 0.000150 AC XY: 109AN XY: 727062
GnomAD4 genome ? AF: 0.00137 AC: 209AN: 152334Hom.: 1 Cov.: 32 AF XY: 0.00123 AC XY: 92AN XY: 74494
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 24, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DNAAF3-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 06, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at